Description
Amoxicillin/Clavulanate combines an extended-spectrum β-lactam antibiotic with a β-lactamase inhibitor. Amoxicillin is an extended-spectrum ß-lactam antibiotic with a structure similar to that of ampicillin. It is effective against a variety of ß-lactamase negative bacteria including E. coli and various Streptococcus and Staphylococcus bacteria; however, when combined with clavulanic acid, ß-lactamase enzymes are irreversibly inactivated. Consequently, amoxicillin/clavulanate is effective against ß-lactamase-negative and ß-lactamase-positive bacteria.
Penicillins are a type of β-lactam antibiotic consisting of a four-membered β-lactam ring bound to a five-membered thiazolidine ring. This two-ring system causes distortion of the β-lactam amide bond, resulting in decreased resonance stabilization and increased reactivity. β-lactams inhibit the formation of peptidoglycan cross-links within bacterial cell walls by targeting penicillin-binding proteins or PBPs. Consequently, the bacterial cell wall becomes weak and cytolysis occurs. Resistance to β-lactam antibiotics occurs in the presence of cells containing plasmid encoded extended spectrum β-lactamases or ESBLs.
Product Specifications
Amoxicillin/ Clavulanate
Augmentin® (by GSK)
MOLECULAR BIOLOGY GRADE
Formula: C24H27KN4O10S
MW: 602.66 g/mol
Storage/Handling: Store desiccated at 2-8°C.
PubChem Chemical ID: 23665637